Zogenix
ZGNX
$26.68
Share price
0.00%
Change (1 day)
41.39%
Change (1 year)
Categories
Revenue for Zogenix (ZGNX)
Revenue in 2021 (TTM): $81.69 M
According to Zogenix's latest financial reports the company's current revenue (TTM) is $81.69 M. In 2020 the company made a revenue of $13.64 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zogenix from 2010 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $81.69 M | 498.78% |
| 2020 | $13.64 M | |
| 2016 | $28.85 M | 6.14% |
| 2015 | $27.18 M | -32.94% |
| 2014 | $40.53 M | 22.78% |
| 2013 | $33.01 M | -25.52% |
| 2012 | $44.32 M | 17.96% |
| 2011 | $37.57 M | 60.3% |
| 2010 | $23.44 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 113,770.56% | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | 71,507.64% | 🇺🇸 USA |
 Eli Lilly LLY | $34.12 B | 41,672.17% | 🇺🇸 USA |
 Merck MRK | $60.11 B | 73,487.05% | 🇺🇸 USA |
 Cardinal Health CAH | $216.14 B | 264,492.18% | 🇺🇸 USA |
 Antares Pharma ATRS | $0.18 B | 125.22% | 🇺🇸 USA |
 Alkermes ALKS | $1.66 B | 1,936.22% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $90.12 M | 10.32% | 🇺🇸 USA |